Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive.

ACS Chemical Biology
Jessica L Childs-DisneyMatthew D Disney

Abstract

RNA is an important drug target, but it is difficult to design or discover small molecules that modulate RNA function. In the present study, we report that rationally designed, modularly assembled small molecules that bind the RNA that causes myotonic dystrophy type 1 (DM1) are potently bioactive in cell culture models. DM1 is caused when an expansion of r(CUG) repeats, or r(CUG)(exp), is present in the 3' untranslated region (UTR) of the dystrophia myotonica protein kinase (DMPK) mRNA. r(CUG)(exp) folds into a hairpin with regularly repeating 5'CUG/3'GUC motifs and sequesters muscleblind-like 1 protein (MBNL1). A variety of defects are associated with DM1, including (i) formation of nuclear foci, (ii) decreased translation of DMPK mRNA due to its nuclear retention, and (iii) pre-mRNA splicing defects due to inactivation of MBNL1, which controls the alternative splicing of various pre-mRNAs. Previously, modularly assembled ligands targeting r(CUG)(exp) were designed using information in an RNA motif-ligand database. These studies showed that a bis-benzimidazole (H) binds the 5'CUG/3'GUC motif in r(CUG)(exp.) Therefore, we designed multivalent ligands to bind simultaneously multiple copies of this motif in r(CUG)(exp). Herein, w...Continue Reading

References

Mar 1, 1995·The Journal of Cell Biology·K L TanejaR H Singer
Dec 23, 2000·The Journal of Biological Chemistry·N A TimchenkoL T Timchenko
Feb 22, 2001·Science·J C VenterX Zhu
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
May 22, 2001·Molecular and Cellular Biology·B ThyagarajanM P Calos
Jul 4, 2001·Nucleic Acids Research·M FardaeiM G Hamshere
Oct 9, 2001·Human Molecular Genetics·A MankodiC A Thornton
Dec 13, 2003·Science·Rahul N KanadiaMaurice S Swanson
Jul 17, 2004·The EMBO Journal·Thai H HoThomas A Cooper
Sep 1, 2004·Neuromuscular Disorders : NMD·Partha S SarkarSita Reddy
Jan 11, 2005·Neuromuscular Disorders : NMD·John W Day, Laura P W Ranum
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Rahul N KanadiaMaurice S Swanson
Oct 10, 2006·Oncogene·G A Calin, C M Croce
Jan 18, 2007·PloS One·Christopher S Raymond, Philippe Soriano
Mar 3, 2007·Neuromuscular Disorders : NMD·Yuriko NezuShoichi Ishiura
Jun 30, 2007·Nature Reviews. Drug Discovery·Elizabeth IornsAlan Ashworth
Nov 3, 2007·ACS Chemical Biology·Jessica L Childs-DisneyMatthew D Disney
Feb 12, 2008·Nucleic Acids Research·Robert J Osborne, Charles A Thornton
Jul 26, 2008·Journal of the American Chemical Society·Matthew D DisneyJessica L Childs-Disney
Oct 14, 2009·Proceedings of the National Academy of Sciences of the United States of America·M Bryan WarfJ Andrew Berglund
Jan 9, 2010·Chembiochem : a European Journal of Chemical Biology·Matthew D DisneyJessica L Childs-Disney
Nov 23, 2010·Human Molecular Genetics·Masayuki NakamoriCharles A Thornton
May 25, 2011·Journal of the American Chemical Society·Sai Pradeep VelagapudiMatthew D Disney

❮ Previous
Next ❯

Citations

Sep 6, 2012·ACS Chemical Biology·Matthew D DisneyJessica L Childs-Disney
Jun 29, 2013·Nature Communications·Jessica L Childs-DisneyMatthew D Disney
Dec 21, 2012·Human Gene Therapy·Zhihua Gao, Thomas A Cooper
May 11, 2013·Nucleic Acids Research·Amin Haghighat JahromiMaria Spies
Feb 11, 2014·Nature Chemical Biology·Sai Pradeep VelagapudiMatthew D Disney
Jan 8, 2014·Acta Neuropathologica·Tania F GendronLeonard Petrucelli
Jul 20, 2014·Neurologic Clinics·Charles A Thornton
May 7, 2014·Nucleic Acids Research·Jason W HoskinsCharles A Thornton
Sep 4, 2014·Nucleic Acids Research·Patryk KoniecznyKrzysztof Sobczak
Mar 14, 2013·ACS Chemical Biology·Amin Haghighat JahromiSteven C Zimmerman
Jul 13, 2013·Expert Opinion on Therapeutic Targets·Tania F GendronLeonard Petrucelli
Oct 31, 2015·Annual Review of Pharmacology and Toxicology·Jessica L Childs-Disney, Matthew D Disney
Oct 27, 2015·Journal of Chemical Theory and Computation·Ilyas YildirimGeorge C Schatz
Feb 18, 2015·Current Opinion in Structural Biology·Matthew D Shortridge, Gabriele Varani
Dec 13, 2012·BioFactors·Urszula PolakMarek Napierala
Jan 3, 2013·Angewandte Chemie·Lirui Guan, Matthew D Disney
Aug 29, 2014·Angewandte Chemie·Suzanne G RzuczekMatthew D Disney
Dec 17, 2014·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Anthony Chau, Auinash Kalsotra
Jun 19, 2014·ChemMedChem·Lien NguyenSteven C Zimmerman
Dec 1, 2015·Methods : a Companion to Methods in Enzymology·Martyna O Urbanek, Wlodzimierz J Krzyzosiak
May 12, 2015·Organic & Biomolecular Chemistry·Jessica E Wynn, Webster L Santos
Jun 24, 2015·Journal of Medicinal Chemistry·Ruth B SiboniJ Andrew Berglund
Jul 4, 2015·Neuron·Viachaslau Bernat, Matthew D Disney
Mar 12, 2013·Neuron·David L NelsonStephen T Warren
May 16, 2014·RNA Biology·Marzena WojciechowskaWlodzimierz J Krzyzosiak
Apr 21, 2016·ACS Chemical Biology·Matthew D DisneyJessica L Childs-Disney
May 27, 2014·Bioorganic & Medicinal Chemistry Letters·Kejia DingThomas Hermann
Dec 17, 2014·Human Molecular Genetics·Ramesh S YadavaMani S Mahadevan
Dec 21, 2013·Organic & Biomolecular Chemistry·Matthew D DisneyJessica L Childs-Disney
Dec 23, 2014·Neurodegenerative Disease Management·Christopher J DonnellyRita Sattler
Jun 2, 2016·Nature Communications·Wang-Yong YangMatthew D Disney
Jun 3, 2016·ACS Chemical Biology·David W CrawfordBrian R McNaughton
Sep 14, 2013·ACS Chemical Biology·Leslie A CoonrodJ Andrew Berglund
Nov 6, 2013·Journal of Medicinal Chemistry·Amin Haghighat JahromiSteven C Zimmerman
Aug 31, 2013·Analytical Chemistry·Janghyun LeeHashim M Al-Hashimi
Sep 17, 2013·ACS Chemical Biology·Suzanne G RzuczekMatthew D Disney
Sep 7, 2016·Cell Chemical Biology·Colleen M ConnellyJohn S Schneekloth
Dec 13, 2016·Nature Chemical Biology·Suzanne G RzuczekMatthew D Disney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.